Knowledge Distillery

The objective of this prospective, multicentre, observational cohort study was to assess neurological manifestations and quality of life (QoL) three…

Coronavirus disease have been reported to be associated with several neurological manifestations such as stroke, Guillain-Barré syndrome,…

Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and…

This nationwide study assessed the impact of the pandemic on stroke hospitalisation rates, patient characteristics, and 30‐day case fatality rates.

The effects of the COVID‐19 pandemic on telemedical care have not been described on a national level.

The authors conducted a longitudinal case-control 18F-FDG-PET study in patients diagnosed with COVID-19-related encephalopathy.

The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length SARS-CoV-2 spike protein in a…

Many pregnant persons in the United States are receiving messenger RNA (mRNA) COVID-19 vaccines, but data are limited on their safety in pregnancy.

Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the…

The mainstay of control of the COVID-19 pandemic is vaccination against SARS-CoV-2.

In this article the authors report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving…

Whether or not persons who have already been infected SARS-CoV-2 should be vaccinated is unclear.